Back

Prognostic value of atrial fibrillation duration and left atrial low-voltage area after atrial fibrillation ablation: insights from the SUPPRESS AF study

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Masato Kawasaki

Osaka General Medical Center, Osaka (Japan)

2 More presentations in this session

Presentation thumbnail
Comparison of clinical efficacy of pulsed field ablation and second-generation cryoballoon ablation in the treatment of paroxysmal atrial fibrillation
Doctor X. Li (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Procedural outcomes and safety of pulse field ablation using the circular multielectrode array catheter (Pulse Select Catheter) in atrial fibrillation: A real-world prospective study
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation
thumbnail
Congress Presentation
Size-dependent efficacy of low-voltage area ablation in persistent atrial fibrillation: a subanalysis of the SUPPRESS-AF trial
thumbnail
Congress Presentation
Long-term prognosis in patients undergoing atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources